JP2010029596A - Medicinal solution application kit - Google Patents

Medicinal solution application kit Download PDF

Info

Publication number
JP2010029596A
JP2010029596A JP2008197733A JP2008197733A JP2010029596A JP 2010029596 A JP2010029596 A JP 2010029596A JP 2008197733 A JP2008197733 A JP 2008197733A JP 2008197733 A JP2008197733 A JP 2008197733A JP 2010029596 A JP2010029596 A JP 2010029596A
Authority
JP
Japan
Prior art keywords
chemical liquid
chemical
chemical solution
shaft
liquid application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008197733A
Other languages
Japanese (ja)
Other versions
JP4944070B2 (en
Inventor
Hiroyuki Nakamura
裕之 中村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aglis Co Ltd
Toray Fine Chemicals Co Ltd
Original Assignee
Aglis Co Ltd
Toray Fine Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aglis Co Ltd, Toray Fine Chemicals Co Ltd filed Critical Aglis Co Ltd
Priority to JP2008197733A priority Critical patent/JP4944070B2/en
Publication of JP2010029596A publication Critical patent/JP2010029596A/en
Application granted granted Critical
Publication of JP4944070B2 publication Critical patent/JP4944070B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

<P>PROBLEM TO BE SOLVED: To provide a medicinal solution application kit capable of applying a necessary and sufficient quantity of medical solution to an affected part without dripping of the medicinal solution when used, without excessive remaining of the excess medicinal solution after use, and without hindrance to the sealing performance by the attachment of the medicinal solution to a sealed part when manufactured. <P>SOLUTION: The medicinal solution application kit includes a medicinal solution applicator 1 having a medicinal solution-applying part 2 made of a sponge body and a shaft part 3; a storage case 4 having a medicinal solution-applying part storage recess 5 and a shaft storage recess 4a; and a sheet lid. The medicinal solution in the same quantity as the quantity that can be retained in the applying part 2 is stored together with the applying part 2 within the storage recess 5, and the shaft part 3 is stored within the shaft part storage recess 4a. The storage case 4 is sealed with the sheet lid. The medicinal solution application kit with the above structure is provided. <P>COPYRIGHT: (C)2010,JPO&INPIT

Description

本発明は、消毒薬などの薬液を患部に塗布するのに用いる薬液塗布用キット、すなわち、開封すれば即座に薬液を患部に塗布することができるように薬液塗布具を容器内に収容してなる薬液塗布用キットに関する。   The present invention is a chemical solution application kit used for applying a chemical solution such as a disinfectant to an affected area, that is, a chemical application device is accommodated in a container so that the chemical solution can be immediately applied to the affected area when opened. It is related with the chemical | medical solution application kit which becomes.

患部に消毒薬などの薬液を塗布する場合、綿棒や綿球などに薬液を含浸させて塗布するのが一般的である。しかし、患部に薬液を塗布するたびに薬液を別途用意して含浸させることは面倒であるため、予め薬液を含浸させた綿球や綿棒などを容器に封入して薬液塗布用キットして提供することが提案されている。   When applying a chemical solution such as a disinfectant to the affected area, it is common to apply a chemical solution to a cotton swab or cotton ball. However, since it is cumbersome to prepare and impregnate the chemical solution separately every time the chemical solution is applied to the affected part, a cotton ball or a cotton swab impregnated with the chemical solution is enclosed in a container and provided as a chemical solution application kit. It has been proposed.

例えば特許文献1には、薬液を含浸させた複数の綿球を、容器に複数形成された収容凹部にそれぞれ挿入し、各収容凹部の開口部をシール部材によって密封してなる構成の薬液塗布用キットが開示されている。   For example, in Patent Document 1, a plurality of cotton balls impregnated with a chemical solution are respectively inserted into storage recesses formed in a container, and the opening of each storage recess is sealed with a seal member. A kit is disclosed.

特許文献2には、軸体の端部に塗布液含浸部を設けた塗布液含浸綿棒と、前記塗布液含浸部を収容する凹部、および、この凹部から連続し塗布液含浸部に隣接する軸体を収容する溝部が形成されたカップ部材と、このカップ部材の開口面上に配置して凹部内を密閉する被覆フィルムとを備えた薬液塗布用キットが開示されている。   Patent Document 2 discloses a coating liquid-impregnated cotton swab provided with a coating liquid-impregnated portion at the end of a shaft body, a concave portion that accommodates the coating liquid-impregnated portion, and a shaft that is continuous from the concave portion and adjacent to the coating liquid-impregnated portion. There is disclosed a chemical solution coating kit including a cup member in which a groove portion for accommodating a body is formed and a covering film that is disposed on the opening surface of the cup member and seals the inside of the recess.

実開昭62−172449号公報の請求項1及び図1Claim 1 and FIG. 1 of Japanese Utility Model Laid-Open No. 62-172449. 特開2007−319535号公報の請求項1及び図1Claim 1 and FIG. 1 of Japanese Patent Laid-Open No. 2007-319535

従来使用されていた綿棒は、薬液を吸収し保持し得る量(以下「抱液可能量」ともいう)が十分でないため、薬液を含浸させた綿棒を一回塗布するだけでは患部に十分な量の薬液を塗布することが難しいという課題を抱えていた。他方、多くの薬液を綿棒と共に容器内に収容すると、容器内で薬液がダブつき、綿棒を摘み上げた際に薬液が滴り落ちたり、多くの薬液が使用後に残って無駄を生じたり、蓋体をシールする時にシール部分に薬液が付着して密閉性を妨げたりするなどの問題を生じることになる。   The amount of cotton swabs that have been used in the past is not enough to absorb and retain the drug solution (hereinafter also referred to as “amount of liquid that can be held”), so it is sufficient to apply only one swab impregnated with the drug solution to the affected area. It was difficult to apply the chemical solution. On the other hand, if a lot of chemicals are stored in a container together with a cotton swab, the chemical will drip inside the container, and when the cotton swab is picked up, the chemicals may drip, or a lot of chemicals may remain after use, resulting in waste. When sealing, the chemical solution adheres to the seal portion, which causes problems such as hindering sealing.

そこで本発明の目的は、患部に薬液を容易に塗布することができ、しかも、使用する際に、薬液が滴り落ちたり、使用後に余分な薬液が過剰に残ったり、製造時にシール部分に薬液が付着して密閉性を妨げることのない薬液塗布用キットを提供することにある。   Therefore, an object of the present invention is to easily apply a chemical solution to an affected area, and when used, the chemical solution drippings, an excessive chemical solution remains after use, or a chemical solution is applied to the seal part at the time of manufacture. It is an object of the present invention to provide a chemical solution coating kit that does not adhere and prevent the sealing performance.

かかる目的のため、本発明は、スポンジ体からなる薬液塗布部、及び軸部を有する薬液塗布具と、前記薬液塗布部を収容する薬液塗布部収容凹部、及びこの薬液塗布部収容凹部と連通した、軸部を収容する軸部収容凹部を有する収容容器と、薬液塗布部収容凹部及び軸部収容凹部を被覆し得るシート蓋体と、を備えた薬液塗布用キットであって、薬液塗布部収容凹部内に、薬液塗布部と共に当該薬液塗布部の抱液可能量と同量の薬液を収容し、軸部収容凹部内に軸部を収容し、前記薬液塗布部収容凹部及び軸部収容凹部をシート蓋体で密閉してなる構成を備えた薬液塗布用キットを提案する。   For this purpose, the present invention is in communication with a chemical liquid applicator having a chemical liquid application part made of a sponge body and a shaft part, a chemical liquid application part accommodating recess for accommodating the chemical liquid application part, and the chemical liquid application part accommodating recess. A chemical solution application kit comprising: a storage container having a shaft portion receiving recess for storing the shaft portion; and a sheet lid body capable of covering the drug solution applying portion receiving recess and the shaft portion receiving recess. In the recess, together with the chemical solution application part, the same amount of liquid chemical as the liquid application part can be held is accommodated, the shaft part is accommodated in the shaft part accommodation recess, and the chemical solution application part accommodation recess and the shaft part accommodation recess are provided. A chemical solution application kit having a configuration in which a sheet lid is hermetically sealed is proposed.

本発明の薬液塗布用キットは、シート蓋体を収容容器から剥がして薬液塗布具を取り出せば、この薬液塗布具を使用して即座に薬液を患部に塗布することができる。しかも、薬液塗布部収容凹部内に収容する薬液を、薬液塗布部の抱液可能量と同量に調整したことにより、患部に必要十分な量の薬液を塗布することができるばかりか、余分な薬液が薬液塗布部収容凹部内に存在しないから、患部に薬液を塗布する際に薬液が滴り落ちたり、使用後に余分な薬液が過剰に残ったり、製造時にシール部分に薬液が付着して密閉性を妨げることがない。   In the chemical solution application kit of the present invention, the chemical solution can be immediately applied to the affected part by using the chemical solution applicator by removing the sheet lid from the container and taking out the chemical applicator. In addition, by adjusting the amount of the chemical solution stored in the chemical solution application portion receiving recess to the same amount as the amount of liquid that can be held in the chemical solution application portion, it is possible not only to apply a necessary and sufficient amount of the chemical solution to the affected area, but also an extra amount. Since there is no chemical solution in the concave part where the chemical solution is applied, the chemical solution dripped when applying the chemical solution to the affected area, excess chemical solution remains after use, or the chemical solution adheres to the seal part during manufacturing and seals Will not be disturbed.

発明を実施するための形態BEST MODE FOR CARRYING OUT THE INVENTION

以下、本発明の好適な実施形態について説明する。但し、本発明が下記に説明する実施形態に限定されるものではない。   Hereinafter, preferred embodiments of the present invention will be described. However, the present invention is not limited to the embodiments described below.

本発明の一実施形態に係る薬液塗布用キット(以下「本薬液塗布用キット」という)は、図1に示すように、スポンジ体からなる薬液塗布部2、及び軸部3を有する薬液塗布具1と、前記薬液塗布部2を収容する薬液塗布部収容凹部5、及び軸部3を収容する軸部収容凹部4aを有する収容容器4と、薬液塗布部収容凹部5内に収容する薬液と、薬液塗布部収容凹部5及び軸部収容凹部4aを被覆し得るシート蓋体(図示せず)と、を備えたものである。   A chemical solution application kit according to an embodiment of the present invention (hereinafter referred to as “this chemical solution application kit”) includes a chemical solution application part 2 composed of a sponge body and a chemical part applicator as shown in FIG. 1, a container 4 having a chemical liquid application part accommodating recess 5 for accommodating the chemical liquid application part 2, a shaft part accommodating recess 4 a for accommodating the shaft part 3, a chemical liquid accommodated in the chemical liquid application part accommodating recess 5, And a sheet lid (not shown) capable of covering the chemical solution application portion receiving recess 5 and the shaft portion receiving recess 4a.

(薬液塗布具2)
薬液塗布部2は、OH基を有するセルロースを主成分とするスポンジ体から形成するのが好ましい。
親水基であるOH基を有するセルロースを主成分とするスポンジ体から薬液塗布部2を形成すれば、薬液、特に水溶液からなる薬液(例えばポピドンヨード液)となじみ易く、薬液を吸収し保持し得る量、すなわち抱液可能量を高めることができる。しかも、薬液を含んだウェット状態になると表面が柔らかくなり、柔らかい感触で塗布することができる。
(Chemical solution applicator 2)
The chemical solution application part 2 is preferably formed from a sponge body mainly composed of cellulose having an OH group.
If the chemical solution application part 2 is formed from a sponge body mainly composed of cellulose having an OH group which is a hydrophilic group, the chemical solution, particularly a chemical solution consisting of an aqueous solution (for example, a popidone iodine solution) is easily compatible and can absorb and retain the chemical solution. That is, it is possible to increase the amount of liquid that can be held. Moreover, when the wet state containing the chemical solution is reached, the surface becomes soft and can be applied with a soft feel.

この際、前記スポンジ体は、例えば強度を高めるために、母材繊維であるセルロースに補強繊維を含んでいてもよい。補強繊維としては、綿(コットン)や亜麻、ラミー、パルプ等を単独またはそれらを組合せて使用することができる。
例えば、セルロース100重量部に対して補強繊維、例えば綿繊維を20〜50重量部含有するものが好ましく、特に20〜40重量部含有するものが好ましい。補強繊維を20〜50重量部含有させることによって、引張強度や保形性を高めることができ、多くの薬液を含んでいてもスポンジの形状を保つことができ、患部に薬液を塗布し易くなる。
In this case, the sponge body may contain reinforcing fibers in cellulose, which is a base fiber, in order to increase the strength, for example. As the reinforcing fiber, cotton (cotton), flax, ramie, pulp and the like can be used alone or in combination.
For example, those containing 20 to 50 parts by weight of reinforcing fibers, such as cotton fibers, with respect to 100 parts by weight of cellulose are preferred, and those containing 20 to 40 parts by weight are particularly preferred. By containing 20 to 50 parts by weight of the reinforcing fiber, the tensile strength and shape retention can be increased, the shape of the sponge can be maintained even if a lot of chemicals are contained, and the chemical solution can be easily applied to the affected part. .

薬液塗布部2のスポンジ体の空隙率は95〜99%であるのが好ましい。スポンジ体の空隙率が95〜99%であれば、薬液を吸収し保持する量、すなわち抱液可能量を高めることができ、しかも、吸収保持した薬液を容易に放出するから、薬液を容易に塗布することができる。
空隙率は、下記式(1)で算出される値である。
(1)・・空隙率=(真密度−見掛密度)×100/真密度
なお、見掛密度とは、スポンジ体の見掛体積(空隙含)に対する重量の割合であり、真密度とは、スポンジ体の見掛体積から空隙の容積を差し引いたスポンジ体構成材料の実質体積に対する重量の割合である。
The porosity of the sponge body of the chemical solution application part 2 is preferably 95 to 99%. If the porosity of the sponge body is 95 to 99%, it is possible to increase the amount of the drug solution that is absorbed and retained, that is, the amount of liquid that can be held, and the absorbed and retained chemical solution is easily released. Can be applied.
The porosity is a value calculated by the following formula (1).
(1) .. Porosity = (true density−apparent density) × 100 / true density The apparent density is the ratio of the weight to the apparent volume (including voids) of the sponge body, and the true density is The ratio of the weight to the substantial volume of the sponge body constituent material obtained by subtracting the void volume from the apparent volume of the sponge body.

薬液塗布部2のスポンジ体の空隙は、外部に連通した空隙であるのが好ましい。後述するように、添加した芒硝結晶を溶出させる方法で空隙を形成する場合には、空隙は外部に連通した空隙となる。   It is preferable that the space | gap of the sponge body of the chemical | medical solution application part 2 is a space | gap connected to the exterior. As will be described later, when the void is formed by the method of eluting the added mirabilite crystal, the void is a void communicating with the outside.

薬液塗布部2のスポンジ体の空隙の平均径は、0.1mm〜3.3mmであるのが好ましく、特に0.5mm〜2.0mm、中でも特に0.7mm〜0.9mmであるのが好ましい。
スポンジ体の空隙率の平均径が3.3mm以下、特に2.0mm以下であれば、薬液を吸収し保持する量、すなわち抱液可能量を高めることができる。
なお、空隙の平均径は、電子顕微鏡で観察して求めることもできるが、後述するように、添加した芒硝結晶を溶出させることにより空隙を形成する製造方法においては、芒硝結晶の粒径と空隙の平均径は略一致するから、芒硝結晶の平均径に読み替えることができる。
The average diameter of the gaps in the sponge body of the chemical solution application part 2 is preferably 0.1 mm to 3.3 mm, particularly 0.5 mm to 2.0 mm, and particularly preferably 0.7 mm to 0.9 mm. .
If the average diameter of the porosity of the sponge body is 3.3 mm or less, particularly 2.0 mm or less, the amount of the drug solution absorbed and retained, that is, the amount of liquid retention can be increased.
The average diameter of the voids can be obtained by observing with an electron microscope. However, in the production method for forming voids by eluting the added mirabilite crystals, as described later, the particle size and voids of the mirabilite crystals are used. Since the average diameters of these are substantially the same, it can be read as the average diameter of the mirabilite crystals.

薬液塗布部2を構成するスポンジ体の、単位体積当たりの薬液(例えば10%ポピドンヨード液(比重1.036))の抱液可能量は、該スポンジ体の体積と同量であるのが好ましい。具体的には、0.95〜1.10g/cm3、特に0.98〜1.10g/cm3であるのが好ましい。
単位体積当たりの抱液可能量が0.95〜1.10g/cm3であれば、患部に塗布するのに十分な量の薬液を比較的小さな体積のスポンジ体で吸収保持できるから、薬液塗布部2及び薬液塗布部収容凹部5を小さくすることができ、しかも薬液塗布部収容凹部5内に余分な薬液を収容する必要を無くすことができる。
It is preferable that the amount of liquid medicine (for example, 10% popidone iodine solution (specific gravity 1.036)) per unit volume of the sponge body constituting the chemical liquid application unit 2 is the same as the volume of the sponge body. Specifically, it is preferably 0.95 to 1.10 g / cm 3 , particularly preferably 0.98 to 1.10 g / cm 3 .
If the amount of liquid that can be held per unit volume is 0.95 to 1.10 g / cm 3, it is possible to absorb and hold a sufficient amount of chemical solution to be applied to the affected area with a relatively small volume of sponge body. The part 2 and the chemical solution application part accommodating recess 5 can be made smaller, and the need for accommodating extra chemical solution in the chemical solution application part accommodating recess 5 can be eliminated.

単位体積当たりの抱液可能量は、式(2)で算出される値である。
(2)・・単位体積当たりの抱液可能量=吸液時の単位体積重量−乾燥時の単位体積重量
この際、吸液時の単位体積重量は、検体(スポンジ体の直方体)全体を10%ポピドンヨード液に浸し、5分間浸漬させた後、金属メッシュ上に置いて検体から液滴を取り除いた上で測定する単位体積重量である。
The possible amount of liquid hydrate per unit volume is a value calculated by equation (2).
(2) .. Amount of liquid that can be held per unit volume = unit volume weight at the time of liquid absorption−unit volume weight at the time of drying At this time, the unit volume weight at the time of liquid absorption is 10 for the entire specimen (sponge rectangular solid). It is a unit volume weight measured after dipping in a% popidone iodine solution and dipping for 5 minutes and then placing on a metal mesh to remove droplets from the specimen.

薬液塗布部2は、薬液、特に10%ポピドンヨード液の吸液速度が0.03〜0.5s/g、特に0.04〜0.5s/gであるスポンジ体を使用するのが好ましい。
吸液速度が0.03〜0.5s/gであるスポンジ体であれば、収容容器4に薬液塗布具1を挿入した後、薬液塗布部収容凹部5内の薬液塗布部2に薬液を供給する場合に、薬液塗布部2が極めて短時間のうちに薬液を吸収するため、薬液塗布部2に薬液を供給してからシート蓋体をシールするまでの工程を一連の生産ライン上で実施することができ、本薬液塗布用キットの製造をオンラインで行うことができる。また、薬液塗布部2に薬液を注いだ際に瞬時に吸収できるから、薬液がシール部分に跳ねることがなく、シール性をより確実に確保することができる。
It is preferable to use a sponge body having a liquid absorption rate of 0.03 to 0.5 s / g, particularly 0.04 to 0.5 s / g, for the chemical solution application unit 2, particularly a 10% popidone iodine solution.
If the sponge body has a liquid absorption speed of 0.03 to 0.5 s / g, the chemical liquid applicator 1 is inserted into the container 4 and then the chemical liquid is supplied to the chemical liquid application section 2 in the chemical liquid application section receiving recess 5. In this case, since the chemical solution application unit 2 absorbs the chemical solution within an extremely short time, the steps from supplying the chemical solution to the chemical solution application unit 2 to sealing the sheet lid are performed on a series of production lines. The medicinal solution application kit can be manufactured online. Moreover, since it can absorb instantly when a chemical | medical solution is poured into the chemical | medical solution application part 2, a chemical | medical solution does not jump to a seal | sticker part, but can ensure sealing performance more reliably.

薬液の吸液速度は、ステンレス製パッド内に10%ポピドンヨード液を注ぎ、次いで検体(スポンジ体の直方体)をステンレス製パッド内に置いて下部をポピドンヨード液に浸し、検体(スポンジ体)をステンレス製パッド内に置いてから検体の上面部まで吸液するまでの時間を測定し、次の式(4)より算出することができる。
(4)・・吸液速度=測定値(sec)/検体の吸液前の重量(g)
The liquid absorption rate of the chemical solution is 10% popidone iodine solution poured into a stainless steel pad, and then the specimen (sponge rectangular solid) is placed in the stainless steel pad and the lower part is immersed in the popidone iodine liquid, and the specimen (sponge body) is made of stainless steel. It can be calculated from the following equation (4) by measuring the time from when it is placed in the pad until the top surface of the specimen is sucked.
(4) .. Liquid absorption speed = measured value (sec) / weight of sample before liquid absorption (g)

薬液塗布部2は、圧縮前に比べて厚さが1/4〜1/10となるように厚さ方向にのみ圧縮成形されたスポンジ体、言い換えれば、薬液を吸収すると圧縮された分だけ厚さ方向に膨張して復元するスポンジ体を使用するのが好ましい。
圧縮前に比べて厚さが1/4以下となるように厚さ方向にのみ圧縮成形されたスポンジ体を使用することにより、吸液速度を上記の如く高めることができると共に、薬液を吸収した際に厚さ方向に復元膨張し、しかも吸収後の形状が安定するから、薬液塗布部収容凹部5の平面視形状を、薬液塗布部2の平面視形状に沿って若干大きく形成すればよく、しかも安定した状態に薬液塗布部2を収容することができる。なお、圧縮前に比べて厚さが1/10未満となるように厚さ方向にのみ圧縮することは、現在の成形技術上困難である。
かかる観点から、薬液塗布部2は、圧縮前に比べて厚さが1/4〜1/10、中でも1/5〜1/10となるように厚さ方向にのみ圧縮成形されたスポンジ体であるのがより一層好ましい。
The chemical solution application part 2 is a sponge body that is compression-molded only in the thickness direction so that the thickness is 1/4 to 1/10 of that before compression. It is preferable to use a sponge body that expands and restores in the vertical direction.
By using a sponge body that is compression-molded only in the thickness direction so that the thickness is 1/4 or less compared with that before compression, the liquid absorption speed can be increased as described above and the chemical liquid is absorbed. In this case, since the shape is restored and expanded in the thickness direction and the shape after absorption is stabilized, the shape in plan view of the chemical solution application portion receiving recess 5 may be formed slightly larger along the shape in plan view of the chemical solution application portion 2. And the chemical | medical solution application part 2 can be accommodated in the stable state. In addition, it is difficult in the present molding technique to compress only in the thickness direction so that the thickness is less than 1/10 compared to before compression.
From this point of view, the chemical solution application part 2 is a sponge body that is compression-molded only in the thickness direction so as to have a thickness of 1/4 to 1/10, particularly 1/5 to 1/10 of that before compression. Even more preferably.

(スポンジ体の製造方法)
上記のようなスポンジ体の製造方法は特に限定するものではない。好ましい一例としては、木材等からのチップを溶解して繊維素とし、これを水酸化ナトリウム等のアルカリで処理してから二硫化炭素等を添加してビスコースをつくる。このビスコースに硫酸ナトリウム(芒硝)からなる微小芒硝結晶を混合し、シート状あるいはブロック状に成型し、煮沸及び酸凝固させて微小芒硝結晶を溶出させて多孔質化させ、水洗、乾燥、さらには厚み方向に加圧して圧縮させることによって得ることができる。
(Method for producing sponge body)
The method for producing the sponge body as described above is not particularly limited. As a preferred example, chips from wood or the like are dissolved to form fiber, which is treated with an alkali such as sodium hydroxide, and then carbon disulfide or the like is added to make viscose. This viscose is mixed with micro sodium sulfate crystal made of sodium sulfate (sodium salt), molded into a sheet or block, boiled and acid coagulated to elute the micro sodium salt crystal to make it porous, washed with water, dried, Can be obtained by pressing in the thickness direction and compressing.

より具体的な一例としては、木材パルプを水酸化ナトリウム溶液に浸漬し、圧搾後に粉砕してアルカリセルロース(クラム)とし、その後17℃で10時間老成後、二硫化炭素を加えセルロース ザンテートを得、このセルロース ザンテートに繊維長0.1〜5mmの未老成のクラムと水酸化ナトリウム、水を加えて溶解し、ビスコースを得る。
得られたビスコースと平均粒径0.1mm〜3.3mmの微小芒硝結晶とを混合機の中で16〜20℃に保ちながら混合する。この混合物を金型に押出機を介して加圧充填する。その際、押出機周辺の温度も16〜20℃になるように温度調節する。混合物が充填された金型を約90℃の芒硝浴の中で約8時間煮沸し、凝固させて前記微小芒硝結晶を溶出させて多孔質化させ、そして得られた成形体を水洗、乾燥、さらには厚み方向に加圧して圧縮させることによって得ることができる。
但し、かかる方法において、各温度や時間等は調整可能である。
As a more specific example, wood pulp is immersed in a sodium hydroxide solution, pulverized after pressing to alkali cellulose (crumb), then aged at 17 ° C. for 10 hours, and then carbon disulfide is added to obtain cellulose xanthate, An unaged crumb having a fiber length of 0.1 to 5 mm, sodium hydroxide and water are added to this cellulose xanthate and dissolved to obtain viscose.
The obtained viscose and fine sodium silicate crystals having an average particle size of 0.1 mm to 3.3 mm are mixed while being kept at 16 to 20 ° C. in a mixer. This mixture is pressurized and filled into a mold through an extruder. At that time, the temperature around the extruder is adjusted to 16 to 20 ° C. The mold filled with the mixture is boiled for about 8 hours in a mirabilite bath at about 90 ° C., solidified to elute the fine mirabilite crystals, and the resulting compact is washed with water, dried, Furthermore, it can be obtained by pressurizing and compressing in the thickness direction.
However, in this method, each temperature, time, etc. can be adjusted.

この際、芒硝結晶の平均粒径を変化させることにより、スポンジ体内の空隙の大きさを調整することができ、平均粒径の小さな芒硝結晶を使用することによってスポンジ体の空隙を小さくすることができる。よって、芒硝結晶の平均粒径は0.5mm〜2.0mmであるのが特に好ましく、中でも特に0.7mm〜0.9mmであるのがさらに好ましい。   At this time, the size of the voids in the sponge body can be adjusted by changing the average particle size of the mirabilite crystal, and the voids in the sponge body can be reduced by using the mirabilite crystal having a small average particle size. it can. Therefore, the average particle size of the mirabilite crystal is particularly preferably 0.5 mm to 2.0 mm, and more preferably 0.7 mm to 0.9 mm.

厚み方向に圧縮成型して製造されたスポンジ体は、薬液を保持し得る量(抱液可能量)が多いばかりか、吸液速度が速く、しかも薬液を吸収すると所定の厚み(例えば9割前後)に正確に回復するため、薬液の供給量とスポンジ体の体積に応じて薬液塗布部収容凹部5の大きさを正確に設計することができる。   Sponge body manufactured by compression molding in the thickness direction has a large amount of liquid that can hold the drug solution (capable of lysing), has a high liquid absorption rate, and has a predetermined thickness (for example, around 90% when absorbed) Therefore, the size of the chemical solution application portion receiving recess 5 can be accurately designed according to the supply amount of the chemical solution and the volume of the sponge body.

薬液塗布部2の形状は特に限定するものではないが、できるだけ少ない量の薬液を効率良く広範囲に塗布できるように、図1に示すように、扁平な板状体とするのが好ましい。   Although the shape of the chemical solution application part 2 is not particularly limited, it is preferably a flat plate-like body as shown in FIG. 1 so that a small amount of chemical solution can be efficiently and widely applied.

(軸部3)
薬液塗布具1の軸部3は、例えば棒状に形成すればよい。ただし、使い勝手を良好にするように適宜形状に変更可能である。
例えば、図1に示すような、凹凸周面部3bを設けることも可能である。この凹凸周面部3bの形状は適宜変更可能であり、例えば図1に示すように、適宜長さに渡って、円柱状の径大部を形成すると共に、この径大部の周面に、全周に渡る溝乃至突条部3cを複数軸方向に適宜間隔をおいて形成するようにしてもよい。また、適宜長さに渡って軸部に紐を螺旋状に巻き付けたような形状に形成して複数の溝乃至突条部3cを形成するようにしてもよい。
このように凹凸周面部3bの表面に溝乃至突条部3cを形成することにより、軸部3を指で掴み易くなるばかりか、この凹凸周面部3bを収容する凹凸周面部収容部4cの内周面に、当該溝乃至突条部3cと凹凸係合し得る溝乃至突条部を形成することにより、収容容器4内に薬液塗布具1を挿入する際の位置決めが容易になるばかりか、運搬時及び使用時に薬液塗布具1が移動したり脱落したりするのを防ぐことができる。また、不可抗力によって薬液塗布部2に圧力がかかって薬液が染み出した場合でも、薬液が軸部3側に侵入するのを防ぐことができる。かかる点では、凹凸周面部3bを薬液を吸収できる素材から形成するのが好ましい。
この凹凸周面部3bは、軸部3と同一材料で一体に形成することも、軸部3とは別材料で形成しておき、後で軸部3に固着させてなるものでもよい。
(Shaft 3)
What is necessary is just to form the axial part 3 of the chemical | medical solution applicator 1 in the shape of a rod, for example. However, the shape can be appropriately changed so as to improve usability.
For example, as shown in FIG. 1, it is also possible to provide the uneven | corrugated surrounding surface part 3b. The shape of the uneven peripheral surface portion 3b can be appropriately changed. For example, as shown in FIG. 1, a cylindrical large-diameter portion is formed over an appropriate length, and the entire peripheral surface of the large-diameter portion is entirely formed. You may make it form the groove | channel thru | or protrusion 3c over a periphery in the several axial direction at appropriate intervals. Moreover, you may make it form in the shape which wound the string around the axial part over the length suitably, and may form the some groove | channel thru | or protrusion 3c.
By forming the grooves or ridges 3c on the surface of the concavo-convex peripheral surface portion 3b in this manner, not only the shaft portion 3 can be easily grasped with a finger, but also the concavo-convex peripheral surface portion accommodating portion 4c that accommodates the concavo-convex peripheral surface portion 3b. By forming grooves or ridges that can engage with the grooves or protrusions 3c on the peripheral surface, not only positioning when inserting the chemical applicator 1 into the container 4 is facilitated, It is possible to prevent the chemical applicator 1 from moving or dropping during transportation and use. Moreover, even when pressure is applied to the chemical solution application unit 2 due to force majeure and the chemical solution oozes out, the chemical solution can be prevented from entering the shaft portion 3 side. In this respect, it is preferable to form the concavo-convex peripheral surface portion 3b from a material capable of absorbing the chemical solution.
The uneven peripheral surface portion 3b may be formed integrally with the shaft portion 3 with the same material, or may be formed with a material different from that of the shaft portion 3 and fixed to the shaft portion 3 later.

薬液塗布部2に軸部3を固定する手段は任意である。例えば互いに係合するように係合部を設けるようにしてもよいし、圧力で圧着するようにしてもよいし、接着剤で接着するようにしてもよいし、また、インサート成形によって固定するようにしてよい。
より具体的には、図1に示すように、軸部3の先端部に幅広係合部3aを設け、この幅広係合部3aに接着剤を塗布する一方、薬液塗布部2の側面部に切れ込みを入れておき、この切れ込み内に軸部3の幅広係合部3aを挿入させて、軸部3と薬液塗布部2とを接着固定すればよい。この際、軸部3の先端部に幅広係合部3aを設けることにより、軸抜け防止に貢献することはもちろんであるが、薬液塗布部2の剛性を高めることができ、均一且つ広範囲に薬液を塗布し易くなる。
或いは、図3及び図4に示すように、インサート品としての薬液塗布部2を金型内に装填した後、溶融樹脂を注入して薬液塗布部2の端部を挟むようにして軸部3の軸端部に2枚の幅広係合部3a、3aを形成し、幅広係合部3a、3a間で薬液塗布部2の端部を挟んで固定するようにして薬液塗布部2と軸部3とを一体化させることができる。このようにすれば、接着剤を使用しないで一体化することができる。
The means for fixing the shaft portion 3 to the chemical solution application portion 2 is arbitrary. For example, an engagement portion may be provided so as to engage with each other, pressure bonding may be performed, adhesion may be performed with an adhesive, and fixing may be performed by insert molding. You can do it.
More specifically, as shown in FIG. 1, a wide engaging portion 3 a is provided at the tip of the shaft portion 3, and an adhesive is applied to the wide engaging portion 3 a, while A notch is made, and the wide engaging portion 3a of the shaft portion 3 is inserted into the notch, and the shaft portion 3 and the chemical solution applying portion 2 are bonded and fixed. At this time, by providing the wide engaging portion 3a at the distal end portion of the shaft portion 3, it is of course possible to contribute to preventing the shaft from coming off, but the rigidity of the chemical solution applying portion 2 can be increased, and the chemical solution can be uniformly and widely distributed. It becomes easy to apply.
Alternatively, as shown in FIG. 3 and FIG. 4, after the chemical liquid application part 2 as an insert product is loaded in the mold, the molten resin is injected to sandwich the end of the chemical liquid application part 2. Two wide engaging portions 3a and 3a are formed at the end portions, and the chemical solution applying portion 2 and the shaft portion 3 are fixed so that the end portions of the chemical solution applying portion 2 are sandwiched and fixed between the wide engaging portions 3a and 3a. Can be integrated. If it does in this way, it can integrate, without using an adhesive agent.

(収容容器4)
収容容器4は、例えば薬液塗布部2を収容する薬液塗布部収容凹部5と、軸部3を収容する軸部収容凹部4aとを有し、これら薬液塗布部収容凹部5及び軸部3をとり囲むようにシール鍔部4eを備える構成に形成することができる。
(Container 4)
The storage container 4 includes, for example, a chemical solution application portion storage recess 5 that stores the chemical solution application portion 2 and a shaft portion storage recess 4a that stores the shaft portion 3. It can form in the structure provided with the seal collar part 4e so that it may surround.

収容容器4の材質は、特に限定するものではないが、保形性、耐薬品性、薬液の浸透及び揮発を抑えるバリア性などを備えた樹脂からなるシート乃至フィルムから形成されているものが好ましい。例えば、ポリスチレン、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレートなどを好ましく用いることができる。   The material of the container 4 is not particularly limited, but is preferably formed from a sheet or film made of a resin having shape retention, chemical resistance, barrier properties for suppressing chemical penetration and volatilization, and the like. . For example, polystyrene, polyethylene, polypropylene, polyethylene terephthalate and the like can be preferably used.

薬液塗布部収容凹部5は、薬液塗布部2を隙間なくすっぽりと収容することができるように、その平面視形状を、薬液塗布部2の平面視形状に沿って一回り大きく形成するのが好ましい。図1の例では、扁平板状の薬液塗布部2に沿って浅底の凹部として形成してある。
この際、一回り大きくとは、薬液塗布部2は薬液を吸収すると横方向に若干、すなわち全体の15〜25%程度横方向に膨張するため、薬液を供給する前の乾燥状態の平面視幅の15〜25%に加えて若干の余裕(0.5mm〜5mm)を加えて大きい平面視幅に形成するのが好ましい。
他方、薬液塗布部収容凹部5の深さは、薬液塗布部2が薬液を吸収して厚さ方向に復元膨張した際の厚さに若干の余裕(0.5mm〜5mm)を加えた長さの深さに形成するのが好ましい。
It is preferable that the chemical liquid application part accommodating recess 5 is formed to have a larger size in plan view along the planar view shape of the chemical liquid application part 2 so that the chemical liquid application part 2 can be completely accommodated without gaps. . In the example of FIG. 1, a shallow concave portion is formed along the flat plate-shaped chemical solution application portion 2.
At this time, “larger” means that when the chemical solution application part 2 absorbs the chemical solution, it slightly expands in the lateral direction, that is, about 15 to 25% of the whole in the lateral direction. In addition to 15 to 25%, a slight margin (0.5 mm to 5 mm) is preferably added to form a large planar view width.
On the other hand, the depth of the concave portion 5 containing the chemical solution application portion is a length obtained by adding a slight margin (0.5 mm to 5 mm) to the thickness when the chemical solution application portion 2 absorbs the chemical solution and expands and restores in the thickness direction. Preferably, it is formed to a depth of.

軸部収容凹部4aは、薬液塗布部収容凹部5と連通し、且つ軸部3を完全に収容できるように形成すればよい。例えば軸部3の平面視形状に沿って細長い溝状の平面視形状に形成してもよいし、また、図1に示すように、薬液塗布部収容凹部5とは反対側寄り部位に幅広部4bを設けておき、軸部3を指で掴み易くするようにしてもよい。   The shaft housing recess 4a may be formed so as to communicate with the chemical solution coating housing housing recess 5 and to completely store the shaft 3. For example, it may be formed in an elongated groove-like plan view shape along the plan view shape of the shaft portion 3, and as shown in FIG. 4b may be provided so that the shaft portion 3 can be easily grasped with a finger.

また、軸部3に設けた凹凸周面部3bを収容するために凹凸周面部収容部4cを設けるのが好ましい。
この凹凸周面部収容部4cは、凹凸周面部3bの輪郭に沿って一回り大きく凹凸し、且つ凹凸周面部3bと係合して互いに前後方向に移動しないように形成するのが好ましい。例えば、適宜長さに渡って軸部に紐を螺旋状に巻き付けた形状の凹凸周面部3bと係合するように、周面方向の溝4dを並設してなるように形成すればよい。このように形成すれば、上述のように、収容容器内で薬液塗布具1が前後方向に移動するのを防ぐことができるばかりか、軸部収容凹部4aから幅広部4b側に側への万一の薬液流出を防止することもできる。
Moreover, in order to accommodate the uneven | corrugated surrounding surface part 3b provided in the axial part 3, it is preferable to provide the uneven | corrugated surrounding surface part accommodating part 4c.
It is preferable that the concave / convex circumferential surface portion accommodating portion 4c is formed so as to be largely concave / convex along the contour of the concave / convex peripheral surface portion 3b and not to move in the front-rear direction by engaging with the concave / convex peripheral surface portion 3b. For example, the groove 4d in the circumferential direction may be formed side by side so as to engage with the concave / convex circumferential surface portion 3b having a shape in which a string is spirally wound around the shaft portion over an appropriate length. If formed in this way, it is possible not only to prevent the chemical solution applicator 1 from moving in the front-rear direction in the storage container as described above, but also from the shaft portion storage recess 4a to the wide portion 4b side. One chemical outflow can also be prevented.

シール鍔部4eは、シート蓋体を重ねてシールするための部分であり、適宜幅をもって形成するのが好ましい。   The seal collar 4e is a portion for sealing the sheet lid body in an overlapping manner, and is preferably formed with an appropriate width.

(薬液)
収容する薬液の種類は特に制限するものではない。例えばポピドンヨード液、アルコール、過酸化水素などの消毒用薬液、ローション、ベビーオイルなどの化粧液、その他液状の薬液、蒸留水などを挙げることができる。中でも、OH基を有するセルロースを主成分とするスポンジ体とのなじみ易さの観点から、水溶液からなる薬液(例えばポピドンヨード液)が特に好ましい。
(Medical solution)
The type of chemical solution to be stored is not particularly limited. Examples thereof include a disinfecting chemical solution such as popidone iodine solution, alcohol and hydrogen peroxide, a cosmetic solution such as lotion and baby oil, other liquid chemical solutions, and distilled water. Among these, from the viewpoint of easy compatibility with a sponge body mainly composed of cellulose having an OH group, a chemical solution composed of an aqueous solution (for example, a popidone iodine solution) is particularly preferable.

薬液は、薬液塗布部2と共に薬液塗布部収容凹部5内に収容するものであるが、本発明においては、薬液塗布部収容凹部5内に収容する量が重要である。すなわち、薬液塗布部収容凹部5内に、薬液塗布部2と共に薬液塗布部2の抱液可能量と同量、具体的な数値で言えば、抱液可能量の90〜110質量%量の薬液を収容することが重要である。
薬液塗布部2の抱液可能量と同量、すなわち抱液可能量の90〜110質量%量の薬液を収容することで、患部に必要十分な量の薬液を塗布することができるばかりか、余分な薬液が薬液塗布部収容凹部内に存在しないから、薬液が滴り落ちたり、使用後に余分な薬液が過剰に残ったり、製造時にシール部分に薬液が付着して密閉性を妨げるようなことを無くすことができる。
かかる観点から、薬液塗布部収容凹部5内に収容する薬液の量は、薬液塗布部2の抱液可能量の95〜105質量%量が好ましく、特に100〜103質量%量であるのがさらに好ましい。
The chemical solution is to be accommodated in the chemical solution application part accommodating recess 5 together with the chemical solution application part 2, but in the present invention, the amount to be accommodated in the chemical solution application part accommodating recess 5 is important. That is, in the chemical solution application part receiving recess 5, the amount of the liquid solution that can be held in the chemical solution application unit 2 together with the chemical solution application unit 2, that is, in a specific numerical value, 90 to 110% by mass of the liquid holding amount. It is important to accommodate.
By storing the same amount of the lysable amount of the medicinal solution application unit 2, that is, 90 to 110% by mass of the lysable amount, it is possible not only to apply a necessary and sufficient amount of medicinal solution to the affected part, Since there is no excess chemical in the recess where the chemical solution is applied, the chemical may drip, excessive excess chemical may remain after use, or the chemical may adhere to the seal part during manufacturing and prevent sealing. It can be lost.
From this point of view, the amount of the chemical solution accommodated in the chemical solution application part accommodating recess 5 is preferably 95 to 105% by mass, particularly 100 to 103% by mass of the amount of the liquid application part 2 that can be hydrated. preferable.

薬液塗布部収容凹部5内に収容する薬液の量は、患部の種類や大きさ、或いは薬液塗布部収容凹部5の大きさなどにより適宜変更するのが好ましいから、それに合わせて薬液塗布部2の大きさを調整するのが好ましい。   The amount of the chemical solution stored in the chemical solution application portion receiving recess 5 is preferably changed as appropriate depending on the type and size of the affected part, the size of the drug solution application portion storage recess 5, and the like. It is preferable to adjust the size.

(シート蓋体)
シート蓋体は、その材質を特に限定するものではないが、防水性、耐薬品性を備えている必要がある。例えば、樹脂基材シートのシート面に金属薄膜層を積層してなる複合シートを好ましい一例として挙げることができ、具体的には、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレートなどの樹脂基材シートに、アルミ等の金属を蒸着乃至ラミネートして金属薄膜層を積層してなる複合シートなどを好ましく用いることができる。
(Seat lid)
The material of the seat lid is not particularly limited, but it needs to be waterproof and chemical resistant. For example, a composite sheet formed by laminating a metal thin film layer on the sheet surface of a resin base sheet can be cited as a preferred example. Specifically, a resin base sheet such as polyethylene, polypropylene, polyethylene terephthalate, aluminum, etc. A composite sheet obtained by depositing or laminating a metal and laminating a metal thin film layer can be preferably used.

(製造方法)
本薬液塗布用キットの製造方法については、特に制限するものではない。例えば、薬液塗布部収容凹部5内に薬液塗布部2を挿入すると共に、軸部収容凹部4a内に軸部3を挿入するようにして収容容器4内に薬液塗布具1を挿入した後、薬液を薬液塗布部2に注いで供給し、次いで薬液塗布部収容凹部5及び軸部収容凹部4aを被覆するようにシート蓋体を被覆シールするようにして薬液塗布用キットを製造するのが好ましい。
(Production method)
The method for producing the drug solution coating kit is not particularly limited. For example, after inserting the chemical solution application part 2 into the chemical solution application part accommodating recess 5 and inserting the chemical solution applicator 1 into the receiving container 4 so as to insert the shaft part 3 into the shaft part accommodating recess 4a, Is preferably poured into the chemical solution application section 2 and then the chemical solution application kit is manufactured by covering and sealing the sheet lid so as to cover the chemical solution application section receiving recess 5 and the shaft portion receiving recess 4a.

薬液よりも先に薬液塗布具1を収容容器4内に収容し、その後、薬液塗布部収容凹部5内の薬液塗布部2に薬液を供給することにより、薬液を薬液塗布部2が吸収するから薬液を零すことなく供給することができる。
この際、薬液塗布部2に対して、当該薬液塗布部2の抱液可能量と同量の薬液、すなわち抱液可能量の90〜110質量%量の薬液を、薬液塗布部収容凹部5内の薬液塗布部2に供給することにより、シール鍔部4e等に薬液が飛び散るのを防ぐことができ、シート蓋体を密閉状態に被覆シールすることができる。
Since the chemical solution applicator 1 is accommodated in the container 4 prior to the chemical solution, and then the chemical solution is supplied to the chemical solution application unit 2 in the chemical solution application unit receiving recess 5, the chemical solution application unit 2 absorbs the chemical solution. The chemical can be supplied without spilling.
At this time, with respect to the chemical solution application part 2, the same amount of chemical solution as the lysable amount of the chemical solution application part 2, that is, 90 to 110% by mass of the lysable amount is stored in the chemical solution application part housing recess 5. By supplying to the chemical solution application part 2, it is possible to prevent the chemical liquid from splashing on the seal collar 4 e and the like, and the sheet lid can be covered and sealed in a sealed state.

かかる製造方法においては、前述したように、圧縮前に比べて厚さが1/4〜1/10となるように厚さ方向にのみ圧縮成形されたスポンジ体、言い換えれば、薬液を吸収すると圧縮された分だけ厚さ方向に膨張して復元するスポンジ体からなる薬液塗布部2を使用するのが好ましい。
圧縮前に比べて厚さが1/4〜1/10となるように厚さ方向にのみ圧縮成形されたスポンジ体を使用することにより、吸液速度を高めることができると共に、薬液を吸収した際に厚さ方向に復元膨張し、しかも吸収後の形状が安定しているから、薬液塗布部収容凹部5の平面視形状を、薬液塗布部2の平面視形状に沿って若干大きく形成すればよく、しかも安定した状態に薬液塗布部2を収容することができる。
かかる観点から、薬液塗布部2は、圧縮前に比べて厚さが1/4〜1/10、中でも特に1/5〜1/10となるように厚さ方向にのみ圧縮成形されたスポンジ体であるのがより一層好ましい。
In such a manufacturing method, as described above, a sponge body that is compression-molded only in the thickness direction so that the thickness is 1/4 to 1/10 of that before compression, in other words, compresses when absorbing a chemical solution. It is preferable to use the chemical solution application part 2 made of a sponge body that expands and restores in the thickness direction by the amount thus formed.
By using a sponge body that is compression-molded only in the thickness direction so that the thickness is 1/4 to 1/10 of that before compression, the liquid absorption speed can be increased and the chemical solution is absorbed. In this case, since the shape is restored and expanded in the thickness direction and the shape after absorption is stable, the plan view shape of the chemical solution application portion receiving recess 5 is slightly larger along the plan view shape of the chemical solution application portion 2. The chemical solution application unit 2 can be accommodated well in a stable state.
From this point of view, the chemical solution application part 2 is a sponge body that is compression-molded only in the thickness direction so that the thickness is 1/4 to 1/10, particularly 1/5 to 1/10, compared to before compression. Is even more preferred.

また、同じく前述したように、薬液、特に10%ポピドンヨード液の吸液速度が0.03〜0.5s/g、特に0.04〜0.5s/gであるスポンジ体からなる薬液塗布部2を使用するのが好ましい。
吸液速度が0.03〜0.5s/gであるスポンジ体であれば、薬液塗布部収容凹部5内の薬液塗布部2に薬液を注ぐと、薬液塗布部2が瞬時のうちに全体が濡れて薬液を吸収するため、薬液を薬液塗布部2に注いだ際に薬液が飛散することがないばかりか、薬液の供給からシート蓋体をシールするまでの時間が短くて済み、一連の工程を一つの生産ラインで実施することができ、本薬液塗布用キットの生産をオンラインで行うことができる。
Similarly, as described above, the chemical solution application unit 2 made of a sponge body having a liquid absorption rate of a chemical solution, particularly 10% popidone iodine solution, of 0.03 to 0.5 s / g, particularly 0.04 to 0.5 s / g. Is preferably used.
In the case of a sponge body having a liquid absorption speed of 0.03 to 0.5 s / g, when the chemical liquid is poured into the chemical liquid application part 2 in the chemical liquid application part accommodating recess 5, the chemical liquid application part 2 is instantaneously entirely. Since it gets wet and absorbs the chemical solution, when the chemical solution is poured into the chemical solution application unit 2, the chemical solution will not scatter, and the time from the supply of the chemical solution to the sealing of the sheet lid can be shortened. Can be carried out on a single production line, and the production of the drug solution application kit can be performed online.

(使用方法)
本薬液塗布用キットは、シート蓋体を収容容器4から剥がした後、図2に示すように、収容容器4から薬液塗布具1を取り出して薬液塗布具1の薬液塗布部2を患部に当てて移動させれば、薬液塗布部2に含浸した薬液を患部に塗布することができ、過剰な薬液が薬液塗布部収容凹部5内に収容されていないため、薬液が滴り落ちたり、使用後に余分な薬液が過剰に残ったりすることがない。
その際、上記のようなスポンジ体からなる薬液塗布部2であれば、薬液を含浸させた状態でも柔軟性があるので、患部にソフトな塗り心地で薬液を塗布することができる。さらに、セルローススポンジ2を患部に載せただけで、押圧しなくても薬液が浸み出すから、薬液を患部に均一かつ十分に塗布することができる。
(how to use)
In this chemical solution application kit, after the sheet lid is peeled off from the storage container 4, as shown in FIG. 2, the chemical solution application tool 1 is taken out from the storage container 4, and the chemical solution application part 2 of the chemical solution application tool 1 is applied to the affected part. The chemical solution impregnated in the chemical solution application part 2 can be applied to the affected part, and the excessive chemical solution is not accommodated in the chemical solution application part accommodating recess 5, so that the chemical solution may drip or become extra after use. No excessive chemicals remain.
At that time, the chemical solution application part 2 made of a sponge body as described above is flexible even when impregnated with the chemical solution, so that the chemical solution can be applied to the affected area with a soft coating comfort. Furthermore, since the chemical liquid oozes out without being pressed by simply placing the cellulose sponge 2 on the affected area, the chemical liquid can be uniformly and sufficiently applied to the affected area.

(他の実施形態)
薬液塗布部収容凹部5及び軸部3を収容する軸部収容凹部4aのほかに、仕切りを設けると共に、ピンセット、ガーゼ、包帯、止血テープなどの医療器具を収容する医療器具収容凹部を設け、医療器具収容凹部内に医療器具を収容して、医療用キットとして形成することもできる。
(Other embodiments)
In addition to the medical-solution application portion receiving recess 5 and the shaft portion receiving recess 4a for storing the shaft portion 3, a partition is provided, and a medical device receiving recess for receiving medical devices such as tweezers, gauze, bandages, hemostatic tape is provided. A medical instrument can be accommodated in the instrument accommodating recess to form a medical kit.

(用語の説明)
本発明において「主成分」とは、特に記載しない限り、当該主成分の機能を妨げない範囲で他の成分を含有することを許容する意を包含する。この際、当該主成分の含有割合を特定するものではないが、主成分(2成分以上が主成分である場合には、これらの合計量)が組成物中の50質量%以上、特に70質量%以上、中でも特に90質量%以上(100%含む)を占めるのが好ましい。
また、本発明において、「X〜Y」(X,Yは任意の数字)と表現した場合、特にことわらない限り「X以上Y以下」の意と共に、「好ましくはXより大きい」及び「好ましくはYより小さい」の意を包含する。
(Explanation of terms)
In the present invention, the “main component” includes the meaning of allowing other components to be contained within a range that does not interfere with the function of the main component, unless otherwise specified. At this time, the content ratio of the main component is not specified, but the main component (when two or more components are main components, the total amount thereof) is 50% by mass or more, particularly 70% by mass in the composition. %, More preferably 90% by mass or more (including 100%).
Further, in the present invention, when expressed as “X to Y” (X and Y are arbitrary numbers), unless otherwise specified, “X is preferably greater than X” and “ Is less than Y.

以下、各種試験及び実施例に基づいて本発明を説明するが、本発明が下記実施例に限定されるものではない。   Hereinafter, although this invention is demonstrated based on various tests and an Example, this invention is not limited to the following Example.

<薬液塗布部の材料選択試験>
薬液塗布部の材料を選択するために、異なる材料からなる下記検体について下記試験を行い、各検体の物性を比較し、薬液塗布部の材料について検討した。
た。
<Material selection test for chemical application part>
In order to select the material for the chemical solution application part, the following test was performed on the following specimens made of different materials, the physical properties of each specimen were compared, and the material for the chemical solution application part was examined.
It was.

(検体)
検体A:OH基を有するセルロースを主成分とし、セルロース100重量部に対して補強繊維としての綿繊維を30重量部含有する圧縮スポンジ体(圧縮率1/5、空隙率98%、空隙の平均径0.8mm、タテ50.1mm×ヨコ50.6mm×高さ0.8mm、体積2,114mm3
検体B:市販の綿球(20番、タテ24.0mm×ヨコ21.7mm×高さ19.7mm)
検体C:市販の綿棒(5インチ綿棒 小)
(Sample)
Specimen A: Compressed sponge body mainly composed of cellulose having OH group and containing 30 parts by weight of cotton fibers as reinforcing fibers with respect to 100 parts by weight of cellulose (compression rate 1/5, porosity 98%, average of voids) Diameter 0.8mm, Vertical 50.1mm x Width 50.6mm x Height 0.8mm, Volume 2,114mm 3 )
Specimen B: Commercially available cotton ball (No. 20, vertical 24.0 mm × width 21.7 mm × height 19.7 mm)
Specimen C: Commercially available cotton swab (5 inch cotton swab small)

スポンジ体Aは、木材パルプを水酸化ナトリウム溶液に浸漬し、圧搾後に粉砕してアルカリセルロース(クラム)とし、その後17℃で10時間老成後、二硫化炭素を加えセルロース ザンテートを得、このセルロース ザンテートに繊維長0.1〜5mmの未老成のクラムと水酸化ナトリウム、水を加えて溶解し、ビスコースを得、得られたビスコースと平均粒径0.8mmの芒硝結晶を混合機の中で16〜20℃に保ちながら混合し、途中で水を添加し混合物を馴染ませた。この混合物を金型に押出機を介して加圧充填した。その際、押出機周辺の温度も16〜20℃になるように温度調節した。混合物が充填された金型を約90℃の芒硝浴の中で約8時間煮沸し凝固させ、そして得られた成形体を水洗、乾燥、さらには厚み方向に、厚さが1/5となるように加圧して圧縮成型することによって得た圧縮スポンジ体を所定の大きさにカットしたものを用いた。   Sponge body A was obtained by immersing wood pulp in a sodium hydroxide solution, crushing after pressing to alkali cellulose (crumb), and then aging at 17 ° C. for 10 hours, and then adding carbon disulfide to obtain cellulose xanthate. This cellulose xanthate Into the blender, add unripe crumb with a fiber length of 0.1 to 5 mm, sodium hydroxide, and water to dissolve it to obtain viscose. The mixture was kept while maintaining the temperature at 16 to 20 ° C., and water was added to adjust the mixture. This mixture was press-filled into a mold through an extruder. At that time, the temperature around the extruder was adjusted to 16 to 20 ° C. The mold filled with the mixture is boiled for about 8 hours in an about 90 ° C. mirabilite bath and solidified, and the resulting molded body is washed with water, dried, and the thickness becomes 1/5 in the thickness direction. The compression sponge body obtained by pressurizing and compressing as described above was cut into a predetermined size.

(抱液可能量の測定)
ステンレス製パッド内に検体全体が十分に浸かる量の10%ポピドンヨード液を注ぎ、検体全体をポピドンヨード液内に浸して5分間浸漬させた後、金属メッシュ上に置いて検体から液滴を取り除いた上で、吸液時の単位体積重量を測定した。
予め、乾燥状態の検体の重量を測定しておき、下記式(2)より、単位体積当たりの抱液可能量を算出した。
(2)・・単位体積当たりの抱液可能量=吸液時の単位体積重量−乾燥時の単位体積重量
(Measurement of possible amount of liquid)
After pouring 10% popidone iodine solution in an amount sufficient to immerse the entire specimen in a stainless steel pad, immerse the entire specimen in the popidone iodine solution for 5 minutes and place it on a metal mesh to remove the droplets from the specimen. Then, the unit volume weight at the time of liquid absorption was measured.
The weight of the sample in a dry state was measured in advance, and the amount of liquid that could be held per unit volume was calculated from the following formula (2).
(2) ··· Amount of liquid held per unit volume = Unit volume weight at the time of liquid absorption-Unit volume weight at the time of drying

(放液率の測定)
上記の如く、吸液時の単位体積重量を測定し後、検体に200gの加重を掛けて10分放置した後に検体の重量(:放液後の単位体積重量)を測定し、式(3)より放液率を算出した。
(3)・・放液率=(吸液時の単位体積重量−放液後の単位体積重量)×100/(吸液時の単位体積重量−乾燥時の単位体積重量)
(Measurement of liquid discharge rate)
As described above, after measuring the unit volume weight at the time of liquid absorption, the weight of the sample was applied for 200 minutes and allowed to stand for 10 minutes, and then the weight of the sample (: unit volume weight after liquid discharge) was measured. The liquid release rate was calculated.
(3) .. Release rate = (unit volume weight upon liquid absorption−unit volume weight after liquid discharge) × 100 / (unit volume weight upon liquid absorption−unit volume weight upon drying)

(吸液速度)
ステンレス製パッド内に10%ポピドンヨード液を注ぎ、次いで検体(スポンジ体の直方体)をステンレス製パッド内に置いて下部をポピドンヨード液に浸し、検体(スポンジ体)をステンレス製パッド内に置いてから検体の上面部まで吸液するまでの時間を測定し、次の式(4)より算出した。
(4)・・吸液速度=測定値(sec)/検体の吸液前の重量(g)
(Liquid absorption speed)
Pour 10% popidone iodine solution into a stainless steel pad, then place the sample (sponge rectangular parallelepiped) in the stainless steel pad, immerse the lower part in the popidone iodine solution, and place the sample (sponge body) in the stainless steel pad. The time until the liquid was absorbed up to the upper surface was measured and calculated from the following equation (4).
(4) .. Liquid absorption speed = measured value (sec) / weight of sample before liquid absorption (g)

(圧縮率)
検体を含水後、液垂れしない程度に軽く水を絞った状態として、圧縮率を測定した。
圧縮率の測定は、圧縮弾性試験機を用いて測定サンプルに50g/cm2の荷重をかけた時の厚み(T0:初期荷重厚み、mm)を測定した後、200g/cm2の荷重をかけた時の厚み(T1:初期荷重厚み、mm)を測定し、次の式(5)から圧縮率(%)を算出した。
(5)・・圧縮率=(T0−T1)×100/T0
表1には、n=3の平均値を示した。
なお、消毒作業を実施する場合、200g/cm2以下の荷重で消毒箇所に薬液塗布具を押し当てられていると考えられるため、200g/cm2の荷重で圧縮率(%)を測定した。
(Compression rate)
After the specimen was hydrated, the compressibility was measured in a state where water was squeezed lightly enough to prevent dripping.
The compression rate was measured by measuring the thickness (T0: initial load thickness, mm) when a load of 50 g / cm 2 was applied to the measurement sample using a compression elasticity tester, and then applying a load of 200 g / cm 2. The thickness (T1: initial load thickness, mm) was measured, and the compression rate (%) was calculated from the following equation (5).
(5) .. Compression rate = (T0−T1) × 100 / T0
Table 1 shows the average value of n = 3.
In addition, when performing disinfection work, since it is thought that the chemical | medical solution application tool was pressed against the disinfection location with the load of 200 g / cm < 2 > or less, the compressibility (%) was measured with the load of 200 g / cm < 2 >.

Figure 2010029596
Figure 2010029596

検体Aの抱液可能量及び吸液速度は検体Bに比べて極めて大きく、検体Aは多量の薬液を吸収し保持できることが分かった。
また、検体Aの放液率及び圧縮率は検体Cに比べて極めて大きく、検体Aは吸収保持した薬液の多くを放出させることができ、しかも圧縮率が検体C(綿棒)に比べて高いことから、柔らかくて肌に優しいことが分かった。
The amount of the sample A that can be hydrated and the liquid absorption speed were extremely large compared to the sample B, and it was found that the sample A can absorb and retain a large amount of the drug solution.
In addition, the liquid discharge rate and the compression rate of the sample A are extremely larger than those of the sample C, and the sample A can release most of the absorbed and retained chemical solution, and the compression rate is higher than that of the sample C (cotton swab). I found that it was soft and gentle to the skin.

(薬液塗布試験)
ステンレス製パッド内に各検体を置き、10%ポピドンヨード液2000mLを、に注いで薬液を吸収させた後、すぐに肌の上に載せて移動させて、塗布状態を比較検討した。その結果、検体Aは、薬液を瞬時に吸収し、注いだ薬液を全て吸収したが、検体Bは、薬液を全ては吸収できなかった。
また、検体Aは、薬液を吸収した状態で肌の上に載せて移動させただけで薬液を均等に塗布することができ、薬液が垂れるようなことがなかったが、他の検体は、最初に多くの薬液が浸み出して薬液が垂れてしまい、均等に塗布することはできなかった。
(Chemical solution application test)
Each specimen was placed in a stainless steel pad, and 2000 mL of 10% popidone iodine solution was poured into it to absorb the drug solution, and then immediately placed on the skin and moved to compare and examine the application state. As a result, Sample A absorbed the chemical solution instantaneously and absorbed all the poured chemical solution, but Sample B could not absorb all the chemical solution.
In addition, the sample A can be applied evenly by simply moving it on the skin while absorbing the chemical solution, and the chemical solution did not sag. A large amount of the chemical solution oozes out and dripped down, and it was not possible to apply the solution evenly.

(実施例)
検体Aのスポンジ体を使用し、図3及び図4に示すように、厚さ2mm、半径15.5mmの扁平な円板状の薬液塗布部2を形成した。
他法、ポリプロピレンから直径4mm、長さ135mmの丸棒を形成し、その軸端部に、幅広の舌片部(10mm×10mm)3aを適宜間隔を置いて上下に設けると共に、前記丸棒の軸端部寄り部分には、適宜幅(例えば30mm)に渡り凹凸褶曲面部からなる凹凸周面部3bを設けて軸部3を形成した。
そして、インサート品としての薬液塗布部2を金型内に装填した後、樹脂を注入して薬液塗布部2の端部を挟むようにして軸部3の幅広係合部3aを形成して、薬液塗布部2と軸部3とを一体化させて、薬液塗布具1を形成した。
(Example)
Using a sponge body of specimen A, as shown in FIGS. 3 and 4, a flat disc-shaped drug solution application part 2 having a thickness of 2 mm and a radius of 15.5 mm was formed.
Another method is to form a round bar having a diameter of 4 mm and a length of 135 mm from polypropylene, and a wide tongue piece (10 mm × 10 mm) 3 a is provided at the top and bottom of the shaft end portion at appropriate intervals. The shaft portion 3 was formed by providing an uneven circumferential surface portion 3b composed of an uneven curved surface portion over an appropriate width (for example, 30 mm) on the portion near the shaft end portion.
Then, after the chemical solution application part 2 as an insert product is loaded in the mold, the resin is injected to form the wide engaging portion 3a of the shaft portion 3 so as to sandwich the end portion of the chemical solution application part 2, and the chemical application The chemical | medical solution applicator 1 was formed by integrating the part 2 and the shaft part 3.

薬液塗布部収容凹部5に薬液塗布部2を挿入すると共に軸部収容凹部4aに軸部3を挿入するようにして収容容器4内に薬液塗布具1を収容した後、前記薬液塗布部2内の薬液塗布部2に対して上方から、薬液塗布部2の抱液可能量の80〜130(80、90,100、103、105、110、120、130)質量%量の薬液を注ぎ、次いで薬液塗布部収容凹部5及び軸部収容凹部4aを被覆するようにシート蓋体を被覆シールして薬液塗布用キットを製造した。   After the drug solution applicator 1 is inserted into the container 4 so that the drug solution applicator 2 is inserted into the drug solution receiver recess 5 and the shaft 3 is inserted into the shaft receiver recess 4a, From above, a chemical solution in an amount of 80 to 130 (80, 90, 100, 103, 105, 110, 120, 130)% by mass of the liquid application portion 2 of the chemical solution application unit 2 is poured from above. A chemical liquid application kit was manufactured by covering and sealing the sheet lid so as to cover the chemical liquid application part accommodating recess 5 and the shaft part accommodating recess 4a.

この結果、薬液塗布部収容凹部5内に収納する薬液の量、すなわち薬液塗布部2に注ぐ薬液の量は、患部に必要十分な量の薬液を塗布することができる点、薬液塗布部収容凹部5から薬液塗布部2を取り出した際に薬液が滴り落ちる点、使用後に余分な薬液が残る点、製造時にシール部分に薬液が付着する点などから、薬液塗布部2の抱液可能量の90〜110質量%量とするのが好ましく、特に95〜105質量%量、中でも特に100〜103質量%量であるのが好ましいことが分かった。   As a result, the amount of the chemical liquid stored in the chemical liquid application part receiving recess 5, that is, the amount of the chemical liquid poured into the chemical liquid application part 2 can apply a necessary and sufficient amount of chemical liquid to the affected part, 90. Since the chemical solution dripped when the chemical solution application unit 2 is taken out from 5, the extra chemical solution remains after use, the chemical solution adheres to the seal part during manufacture, etc. It was found that the amount was preferably -110% by mass, particularly 95-105% by mass, particularly 100-103% by mass.

本発明の薬液塗布具及びその容器の一実施形態の一例を示した斜視図である。It is the perspective view which showed an example of one Embodiment of the chemical | medical solution applicator of this invention, and its container. 図1の薬液塗布具の使用例を示した概略斜視図である。It is the schematic perspective view which showed the usage example of the chemical | medical solution applicator of FIG. 図1に示した薬液塗布具の変形例を示した斜視図である。It is the perspective view which showed the modification of the chemical | medical solution applicator shown in FIG. 同じく図1に示した薬液塗布具の変形例を示した斜視図である。It is the perspective view which showed the modification of the chemical | medical solution applicator similarly shown in FIG.

符号の説明Explanation of symbols

1 薬液塗布具
2 薬液塗布部
3 軸部
3a 幅広係合部
3b 凹凸周面部
3c 溝乃至突条部
4 収容容器
4a 軸部収容凹部
4b 幅広部
4c 凹凸周面部収容部
4d 溝
4e シール鍔部
5 薬液塗布部収容凹部
DESCRIPTION OF SYMBOLS 1 Chemical solution applicator 2 Chemical solution application part 3 Shaft part 3a Wide engagement part 3b Irregular surface part 3c Groove thru | or protrusion part 4 Container 4a Shaft part accommodation recessed part 4b Wide part 4c Concavity and convexity surface part accommodation part 4d Groove 4e Seal collar part 5 Chemical solution application part receiving recess

Claims (5)

スポンジ体からなる薬液塗布部及び軸部を有する薬液塗布具と、
前記薬液塗布部を収容する薬液塗布部収容凹部、及びこの薬液塗布部収容凹部と連通した、軸部を収容する軸部収容凹部を有する収容容器と、
薬液塗布部収容凹部及び軸部収容凹部を被覆し得るシート蓋体と、を備えた薬液塗布用キットであって、
薬液塗布部収容凹部内に、薬液塗布部と共に当該薬液塗布部の抱液可能量と同量の薬液を収容し、軸部収容凹部内に軸部を収容し、前記薬液塗布部収容凹部及び軸部収容凹部をシート蓋体で密閉してなる構成を備えた薬液塗布用キット。
A chemical liquid applicator having a chemical liquid application part and a shaft part made of a sponge body;
A container containing a chemical liquid application part accommodating recess for accommodating the chemical liquid application part, and a shaft part accommodating concave part communicating with the chemical liquid application part accommodating concave part for accommodating a shaft part;
A chemical liquid application kit comprising: a sheet lid that can cover the chemical liquid application portion accommodating recess and the shaft portion accommodating recess;
In the chemical liquid application part accommodating recess, together with the chemical liquid application part, the same amount of the chemical liquid as the liquid storable amount of the chemical liquid application part is accommodated, the shaft part is accommodated in the shaft part accommodating recess, and the chemical liquid application part accommodating concave part and the shaft A chemical solution application kit having a configuration in which a part housing recess is sealed with a sheet lid.
スポンジ体からなる薬液塗布部及び軸部を有する薬液塗布具と、
前記薬液塗布部を収容する薬液塗布部収容凹部及びこの薬液塗布部収容凹部と連通した、軸部を収容する軸部収容凹部を有する収容容器と、
薬液塗布部収容凹部及び軸部収容凹部を被覆し得るシート蓋体と、を備えた薬液塗布用キットであって、
薬液塗布部収容凹部内に、薬液塗布部と共に当該薬液塗布部の抱液可能量の90〜110質量%量の薬液を収容し、軸部収容凹部内に軸部を収容し、前記薬液塗布部収容凹部及び軸部収容凹部をシート蓋体で密閉してなる構成を備えた薬液塗布用キット。
A chemical liquid applicator having a chemical liquid application part and a shaft part made of a sponge body;
A container having a chemical liquid application part accommodating recess for accommodating the chemical liquid application part and a shaft part accommodating concave part for communicating with the chemical liquid application part accommodating concave part and accommodating the shaft part;
A chemical liquid application kit comprising: a sheet lid that can cover the chemical liquid application portion accommodating recess and the shaft portion accommodating recess;
In the chemical liquid application part accommodating recess, the chemical liquid application part is accommodated together with the chemical liquid application part in an amount of 90 to 110% by mass of the solvable amount of the chemical liquid application part, the shaft part is accommodated in the shaft part accommodating recess, and the chemical liquid application part A chemical solution coating kit having a configuration in which a housing recess and a shaft housing recess are sealed with a sheet lid.
薬液塗布具の軸部の一部に凹凸周面部を設ける一方、収容容器の軸部収容凹部の一部に前記凹凸周面部の外観形状に沿った外観形状を備えた凹凸周面部収容部を設けることを特徴とする請求項1又は2に記載の薬液塗布用キット。   While providing a concave / convex peripheral surface part in a part of the shaft part of the chemical liquid applicator, providing a concave / convex peripheral part containing part having an external shape along the external shape of the concave / convex peripheral surface part in a part of the shaft part containing concave part of the container The kit for chemical | medical solution application | coating of Claim 1 or 2 characterized by the above-mentioned. 薬液塗布部は、空隙率が95〜99%であり、空隙の平均径が0.1mm〜3.3mmであるスポンジ体からなることを特徴とする請求項1〜3の何れかに記載の薬液塗布用キット。   The chemical solution application part according to any one of claims 1 to 3, wherein the chemical solution application part is made of a sponge body having a porosity of 95 to 99% and an average diameter of the voids of 0.1 mm to 3.3 mm. Application kit. 薬液塗布部は、単位体積当たりの抱液可能量が0.95〜1.10g/cm3であるスポンジ体からなることを特徴とする請求項1〜4の何れかに記載の薬液塗布用キット。
The drug solution application kit according to any one of claims 1 to 4, wherein the drug solution application part is made of a sponge body having a liquid retentivity per unit volume of 0.95 to 1.10 g / cm 3. .
JP2008197733A 2008-07-31 2008-07-31 Chemical solution application kit Active JP4944070B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008197733A JP4944070B2 (en) 2008-07-31 2008-07-31 Chemical solution application kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008197733A JP4944070B2 (en) 2008-07-31 2008-07-31 Chemical solution application kit

Publications (2)

Publication Number Publication Date
JP2010029596A true JP2010029596A (en) 2010-02-12
JP4944070B2 JP4944070B2 (en) 2012-05-30

Family

ID=41734787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008197733A Active JP4944070B2 (en) 2008-07-31 2008-07-31 Chemical solution application kit

Country Status (1)

Country Link
JP (1) JP4944070B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012240681A (en) * 2011-05-13 2012-12-10 Seven Dreamers Lab Inc Package containing packaged object, and package
US9642742B2 (en) 2012-10-02 2017-05-09 Harold D. Mansfield Eye drop applicator and drop transfer method

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5726247U (en) * 1980-07-21 1982-02-10
JPS5982419U (en) * 1982-11-24 1984-06-04 ポ−ラ化成工業株式会社 cosmetic tools
JPS6097143U (en) * 1983-12-07 1985-07-02 小林製薬株式会社 Chemical application head
JPS63270065A (en) * 1987-04-27 1988-11-08 Riide Chem Kk Liquid applicator
JPS63184050U (en) * 1987-05-19 1988-11-28
JPH03505293A (en) * 1988-09-30 1991-11-21 ウッターバーグ、デビッド,エス Guarded winged needle assembly
JP2003509161A (en) * 1999-09-24 2003-03-11 ザ、プロクター、エンド、ギャンブル、カンパニー Thin pre-wet structure for collecting body fluids
JP2003292041A (en) * 2002-04-01 2003-10-15 Ribateepu Seiyaku Kk Package for application stick
JP2004065950A (en) * 2002-06-13 2004-03-04 Sanyo:Kk Applicator and application method
JP2004174180A (en) * 2002-11-22 2004-06-24 Heiwa Medic Co Ltd Package for swab with liquid
JP2006500990A (en) * 2002-09-26 2006-01-12 サブ−キュー・インコーポレーテッド System and method for delivering hemostasis promoting substance to blood vessel puncture site by hydraulic pressure
JP2006034416A (en) * 2004-07-23 2006-02-09 Sanritsu Kk Liquid applicator
JP2007506501A (en) * 2003-09-26 2007-03-22 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Tooth cleaning applicator
JP2007515234A (en) * 2003-12-23 2007-06-14 ウ,ツェンドン Cotton swab and method for producing the same
JP2008000258A (en) * 2006-06-21 2008-01-10 Chidori Koga Medicine applicator
JP2008074488A (en) * 2006-09-22 2008-04-03 Aso Seiyaku Kk Swab packaging container
JP2008120450A (en) * 2006-11-13 2008-05-29 Heiwa Medic Co Ltd Applicator package

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5726247U (en) * 1980-07-21 1982-02-10
JPS5982419U (en) * 1982-11-24 1984-06-04 ポ−ラ化成工業株式会社 cosmetic tools
JPS6097143U (en) * 1983-12-07 1985-07-02 小林製薬株式会社 Chemical application head
JPS63270065A (en) * 1987-04-27 1988-11-08 Riide Chem Kk Liquid applicator
JPS63184050U (en) * 1987-05-19 1988-11-28
JPH03505293A (en) * 1988-09-30 1991-11-21 ウッターバーグ、デビッド,エス Guarded winged needle assembly
JP2003509161A (en) * 1999-09-24 2003-03-11 ザ、プロクター、エンド、ギャンブル、カンパニー Thin pre-wet structure for collecting body fluids
JP2003292041A (en) * 2002-04-01 2003-10-15 Ribateepu Seiyaku Kk Package for application stick
JP2004065950A (en) * 2002-06-13 2004-03-04 Sanyo:Kk Applicator and application method
JP2006500990A (en) * 2002-09-26 2006-01-12 サブ−キュー・インコーポレーテッド System and method for delivering hemostasis promoting substance to blood vessel puncture site by hydraulic pressure
JP2004174180A (en) * 2002-11-22 2004-06-24 Heiwa Medic Co Ltd Package for swab with liquid
JP2007506501A (en) * 2003-09-26 2007-03-22 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Tooth cleaning applicator
JP2007515234A (en) * 2003-12-23 2007-06-14 ウ,ツェンドン Cotton swab and method for producing the same
JP2006034416A (en) * 2004-07-23 2006-02-09 Sanritsu Kk Liquid applicator
JP2008000258A (en) * 2006-06-21 2008-01-10 Chidori Koga Medicine applicator
JP2008074488A (en) * 2006-09-22 2008-04-03 Aso Seiyaku Kk Swab packaging container
JP2008120450A (en) * 2006-11-13 2008-05-29 Heiwa Medic Co Ltd Applicator package

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012240681A (en) * 2011-05-13 2012-12-10 Seven Dreamers Lab Inc Package containing packaged object, and package
US9642742B2 (en) 2012-10-02 2017-05-09 Harold D. Mansfield Eye drop applicator and drop transfer method

Also Published As

Publication number Publication date
JP4944070B2 (en) 2012-05-30

Similar Documents

Publication Publication Date Title
CA2642475C (en) Liquid applicator and method for reducing the concentration of by-products from antiseptic
EP1958532A2 (en) Hair treatment application system
US20080083420A1 (en) Hair treatment application system
JP2005119750A (en) Storing and feeding device having porous structure containing biocidal agent
JP2013545605A (en) Cleaning tool
JP5249230B2 (en) Hair treatment application system including absorbent substrate
WO1989005695A1 (en) Liquid applicator
EP1051216A1 (en) Surgical prep solution dispenser and method
JP2000079167A (en) Applicator for dispersible substance, assembly having the same, and method
JP4944070B2 (en) Chemical solution application kit
WO2003000085A2 (en) Nail polish removal system
CN103596528A (en) Wound dressing containing a non-woven and an ointment base for negative pressure therapy
EP2028966A1 (en) Kit for the application of fluid preparation
US20120316518A1 (en) Wound dressing, containing nonwoven fabric and ointment base for negative pressure therapy
JP5833289B2 (en) Chemical solution applicator and chemical solution application kit
CN206079483U (en) Seal structure&#39;s cosmetics body with realize by check valve
NO772087L (en) SURGICAL CLEANING FUNGI.
JP2010029597A (en) Method of manufacturing medicinal solution application kit
JP2005314427A (en) Lip-treating patch
CN209915999U (en) Multifunctional cotton swab with scales
JP2010200809A (en) Disposable chemical container
JP2014094135A (en) Solution applicator
WO2017108717A1 (en) Packaging device for a cosmetic product
WO2008044198A1 (en) Hair treatment application system
KR200482036Y1 (en) Remover set having a cotton swabs with remover capsule

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100301

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20100301

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20100402

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100525

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100722

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100907

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20101129

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120301

R150 Certificate of patent or registration of utility model

Ref document number: 4944070

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150309

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250